Rob Pieters

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 31

Top Topics

Childhood Cancer

Acute Lymphoblastic Leukemia

Hematopoietic Stem Cell

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, Anthony V Moorman, Ajay Vora, Martin Zimmermann, Martin Schrappe, Andrea Biondi, Gabriele Escherich, Jan Stary, Chihaya Imai, Toshihiko Imamura, Mats Heyman, Kjeld Schmiegelow, Rob Pieters
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure? Leukemia 38 (7) (2024)
Aimée S R Westerveld, Pien Roesthuis, Helena J H van der Pal, Dorine Bresters, Marc Bierings, Jacqueline Loonen, Andrica C H de Vries, Marloes Louwerens, Maria M W Koopman, Marry M van den Heuvel-Eibrink, Margriet van der Heiden-van der Loo, Peter Hoogerbrugge, Geert O Janssens, Ronald R de Krijger, Cecile M Ronckers, Rob Pieters, Leontien C M Kremer, Jop C Teepen
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia. Blood cancer journal 14 (1) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, Anthony V Moorman, Ajay Vora, Martin Zimmermann, Martin Schrappe, Andrea Biondi, Gabriele Escherich, Jan Stary, Chihaya Imai, Toshihiko Imamura, Mats Heyman, Kjeld Schmiegelow, Rob Pieters
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure? Leukemia (2024)
Janine Stutterheim, Rachella van der Waarden, Hester A de Groot-Kruseman, Edwin Sonneveld, Valerie de Haas, Rana Dandis, C Ellen van der Schoot, Vincent H J van der Velden, Rob Pieters
Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia? Leukemia (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, Anthony V Moorman, Ajay Vora, Martin Zimmermann, Martin Schrappe, Andrea Biondi, Gabriele Escherich, Jan Stary, Chihaya Imai, Toshihiko Imamura, Mats Heyman, Kjeld Schmiegelow, Rob Pieters
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure? Leukemia 38 (7) (2024)
Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Polonen, Qingsong Gao, Elizabeth D Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, Kenneth J Caldwell, Yunchao Chang, Chelsey Chen, Cheng Cheng, Zhongshan Cheng, John Kim Choi, Valentino Conter, Kristine R Crews, Hester A de Groot-Kruseman, Takao Deguchi, Minenori Eguchi-Ishimae, Hannah Elisa Muhle, Sarah Elitzur, Gabriele Escherich, Burgess B Freeman, Zhaohui Gu, Katie Han, Keizo Horibe, Toshihiko Imamura, Sima Jeha, Motohiro Kato, Edwynn Kean Hui Chiew, Tanya Khan, Michal Kicinski, Stefan Kohrer, Steven Mitchell Kornblau, Rishi Sury Kotecha, Chi-Kong Li, Yen-Chun Liu, Franco Locatelli, Selina M Luger, Elisabeth M Paietta, Atsushi Manabe, Hanne Vibeke Hansen Marquart, Riccardo Masetti, Mellissa Maybury, Pauline Mazilier, Jules P P Meijerink, Sharnise Mitchell, Takako Miyamura, Andrew S Moore, Koichi Oshima, Katarzyna Pawinska-Wasikowska, Rob Pieters, Mollie S Prater, Shondra M Pruett-Miller, Ching-Hong Pui, Chunxu Qu, Michaela Novakova, Noemi Reyes, Kathryn G Roberts, Jacob M Rowe, Atsushi Sato, Kjeld Schmiegelow, Martin Schrappe, Shuhong Shen, Szymon Skoczeń, Orietta Spinelli, Jan Stary, Michael Svatoň, Masatoshi Takagi, Junko Takita, Yanjing Tang, David Trent Teachey, Paul Glyndwr Thomas, Masanori Yoshida, Jan Trka, Elena Varotto, Tiffaney L Vincent, Jun J Yang, Allen Eng-Juh Yeoh, Yinmei Zhou, Martin Zimmermann, Hiroto Inaba, Charles G Mullighan
Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer discovery (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Aimée S R Westerveld, Pien Roesthuis, Helena J H van der Pal, Dorine Bresters, Marc Bierings, Jacqueline Loonen, Andrica C H de Vries, Marloes Louwerens, Maria M W Koopman, Marry M van den Heuvel-Eibrink, Margriet van der Heiden-van der Loo, Peter Hoogerbrugge, Geert O Janssens, Ronald R de Krijger, Cecile M Ronckers, Rob Pieters, Leontien C M Kremer, Jop C Teepen
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia. Blood cancer journal 14 (1) (2024)
Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, Anthony V Moorman, Ajay Vora, Martin Zimmermann, Martin Schrappe, Andrea Biondi, Gabriele Escherich, Jan Stary, Chihaya Imai, Toshihiko Imamura, Mats Heyman, Kjeld Schmiegelow, Rob Pieters
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure? Leukemia 38 (7) (2024)
Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Polonen, Qingsong Gao, Elizabeth D Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, Kenneth J Caldwell, Yunchao Chang, Chelsey Chen, Cheng Cheng, Zhongshan Cheng, John Kim Choi, Valentino Conter, Kristine R Crews, Hester A de Groot-Kruseman, Takao Deguchi, Minenori Eguchi-Ishimae, Hannah Elisa Muhle, Sarah Elitzur, Gabriele Escherich, Burgess B Freeman, Zhaohui Gu, Katie Han, Keizo Horibe, Toshihiko Imamura, Sima Jeha, Motohiro Kato, Edwynn Kean Hui Chiew, Tanya Khan, Michal Kicinski, Stefan Kohrer, Steven Mitchell Kornblau, Rishi Sury Kotecha, Chi-Kong Li, Yen-Chun Liu, Franco Locatelli, Selina M Luger, Elisabeth M Paietta, Atsushi Manabe, Hanne Vibeke Hansen Marquart, Riccardo Masetti, Mellissa Maybury, Pauline Mazilier, Jules P P Meijerink, Sharnise Mitchell, Takako Miyamura, Andrew S Moore, Koichi Oshima, Katarzyna Pawinska-Wasikowska, Rob Pieters, Mollie S Prater, Shondra M Pruett-Miller, Ching-Hong Pui, Chunxu Qu, Michaela Novakova, Noemi Reyes, Kathryn G Roberts, Jacob M Rowe, Atsushi Sato, Kjeld Schmiegelow, Martin Schrappe, Shuhong Shen, Szymon Skoczeń, Orietta Spinelli, Jan Stary, Michael Svatoň, Masatoshi Takagi, Junko Takita, Yanjing Tang, David Trent Teachey, Paul Glyndwr Thomas, Masanori Yoshida, Jan Trka, Elena Varotto, Tiffaney L Vincent, Jun J Yang, Allen Eng-Juh Yeoh, Yinmei Zhou, Martin Zimmermann, Hiroto Inaba, Charles G Mullighan
Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer discovery (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Polonen, Qingsong Gao, Elizabeth D Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, Kenneth J Caldwell, Yunchao Chang, Chelsey Chen, Cheng Cheng, Zhongshan Cheng, John Kim Choi, Valentino Conter, Kristine R Crews, Hester A de Groot-Kruseman, Takao Deguchi, Minenori Eguchi-Ishimae, Hannah Elisa Muhle, Sarah Elitzur, Gabriele Escherich, Burgess B Freeman, Zhaohui Gu, Katie Han, Keizo Horibe, Toshihiko Imamura, Sima Jeha, Motohiro Kato, Edwynn Kean Hui Chiew, Tanya Khan, Michal Kicinski, Stefan Kohrer, Steven Mitchell Kornblau, Rishi Sury Kotecha, Chi-Kong Li, Yen-Chun Liu, Franco Locatelli, Selina M Luger, Elisabeth M Paietta, Atsushi Manabe, Hanne Vibeke Hansen Marquart, Riccardo Masetti, Mellissa Maybury, Pauline Mazilier, Jules P P Meijerink, Sharnise Mitchell, Takako Miyamura, Andrew S Moore, Koichi Oshima, Katarzyna Pawinska-Wasikowska, Rob Pieters, Mollie S Prater, Shondra M Pruett-Miller, Ching-Hong Pui, Chunxu Qu, Michaela Novakova, Noemi Reyes, Kathryn G Roberts, Jacob M Rowe, Atsushi Sato, Kjeld Schmiegelow, Martin Schrappe, Shuhong Shen, Szymon Skoczeń, Orietta Spinelli, Jan Stary, Michael Svatoň, Masatoshi Takagi, Junko Takita, Yanjing Tang, David Trent Teachey, Paul Glyndwr Thomas, Masanori Yoshida, Jan Trka, Elena Varotto, Tiffaney L Vincent, Jun J Yang, Allen Eng-Juh Yeoh, Yinmei Zhou, Martin Zimmermann, Hiroto Inaba, Charles G Mullighan
Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer discovery (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, Anthony V Moorman, Ajay Vora, Martin Zimmermann, Martin Schrappe, Andrea Biondi, Gabriele Escherich, Jan Stary, Chihaya Imai, Toshihiko Imamura, Mats Heyman, Kjeld Schmiegelow, Rob Pieters
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure? Leukemia 38 (7) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Rebecca J van Kalsbeek, Melissa M Hudson, Renée L Mulder, Matthew Ehrhardt, Daniel M Green, Daniel A Mulrooney, Jessica Hakkert, Jaap den Hartogh, Anouk Nijenhuis, Hanneke M van Santen, Antoinette Y N Schouten-van Meeteren, Harm van Tinteren, Lisanne C Verbruggen, Heather M Conklin, Lisa M Jacola, Rachel Tillery Webster, Marita Partanen, Wouter J W Kollen, Martha A Grootenhuis, Rob Pieters, Leontien C M Kremer, null null
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer. Nature medicine (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Rebecca J van Kalsbeek, Melissa M Hudson, Renée L Mulder, Matthew Ehrhardt, Daniel M Green, Daniel A Mulrooney, Jessica Hakkert, Jaap den Hartogh, Anouk Nijenhuis, Hanneke M van Santen, Antoinette Y N Schouten-van Meeteren, Harm van Tinteren, Lisanne C Verbruggen, Heather M Conklin, Lisa M Jacola, Rachel Tillery Webster, Marita Partanen, Wouter J W Kollen, Martha A Grootenhuis, Rob Pieters, Leontien C M Kremer, null null
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer. Nature medicine (2023)
Annelienke M van Hulst, Martha A Grootenhuis, Emma Jacobine Verwaaijen, Raphaele R L van Litsenburg, Letao Li, Bertrand D van Zelst, Linda Broer, Saskia M F Pluijm, Rob Pieters, Marta Fiocco, Erica L T van den Akker, Marry M van den Heuvel-Eibrink
Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important? JCO precision oncology 7 (2023)
Elizabeth A Raetz, Paola Rebora, Valentino Conter, Martin Schrappe, Meenakshi Devidas, Gabriele Escherich, Chihaya Imai, Barbara De Moerloose, Kjeld Schmiegelow, Melissa A Burns, Sarah Elitzur, Rob Pieters, Andishe Attarbaschi, Allen Eng-Juh Yeoh, Ching-Hong Pui, Jan Stary, Gunnar Cario, Nicole Bodmer, Anthony V Moorman, Barbara Buldini, Ajay Vora, Maria Grazia Valsecchi
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rebecca J van Kalsbeek, Melissa M Hudson, Renée L Mulder, Matthew Ehrhardt, Daniel M Green, Daniel A Mulrooney, Jessica Hakkert, Jaap den Hartogh, Anouk Nijenhuis, Hanneke M van Santen, Antoinette Y N Schouten-van Meeteren, Harm van Tinteren, Lisanne C Verbruggen, Heather M Conklin, Lisa M Jacola, Rachel Tillery Webster, Marita Partanen, Wouter J W Kollen, Martha A Grootenhuis, Rob Pieters, Leontien C M Kremer, null null
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer. Nature medicine (2023)
Rob Pieters, Charles G Mullighan, Stephen P Hunger
Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rob Pieters, Hester de Groot-Kruseman, Marta Fiocco, Femke Verwer, Merian Van Overveld, Edwin Sonneveld, Vincent H J van der Velden, H Berna Beverloo, Marc Bierings, Natasja Dors, Valerie de Haas, Peter M Hoogerbrugge, Inge M Van der Sluis, Wim Tissing, Margreet A Veening, Judith M Boer, Monique Den Boer
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rebecca J van Kalsbeek, Melissa M Hudson, Renée L Mulder, Matthew Ehrhardt, Daniel M Green, Daniel A Mulrooney, Jessica Hakkert, Jaap den Hartogh, Anouk Nijenhuis, Hanneke M van Santen, Antoinette Y N Schouten-van Meeteren, Harm van Tinteren, Lisanne C Verbruggen, Heather M Conklin, Lisa M Jacola, Rachel Tillery Webster, Marita Partanen, Wouter J W Kollen, Martha A Grootenhuis, Rob Pieters, Leontien C M Kremer, null null
A joint international consensus statement for measuring quality of survival for patients with childhood cancer. Nature medicine (2023)
Andishe Attarbaschi, Anja Möricke, Christine J Harrison, Georg Mann, Andre Baruchel, Barbara De Moerloose, Valentino Conter, Meenakshi Devidas, Sarah Elitzur, Gabriele Escherich, Stephen P Hunger, Keizo Horibe, Atsushi Manabe, Mignon L Loh, Rob Pieters, Kjeld Schmiegelow, Lewis B Silverman, Jan Stary, Ajay Vora, Ching-Hong Pui, Martin Schrappe, Martin Zimmermann
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/ KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Emma Jacobine Verwaaijen, Annelienke M van Hulst, Marta Fiocco, Annelies Hartman, Martha A Grootenhuis, Saskia M F Pluijm, Rob Pieters, Erica L T van den Akker, Marry M M van den Heuvel-Eibrink
Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study. JMIR research protocols 11 (4) (2022)
Janine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, Julia Alten, Philip Ancliffe, Andishe Attarbaschi, Benoit Brethon, Andrea Biondi, Myriam Campbell, Giovanni Cazzaniga, Gabriele Escherich, Alina Ferster, Rishi Sury Kotecha, Birgitte Lausen, Chi-Kong Li, Luca Lo Nigro, Franco Locatelli, Rolf Marschalek, Claus Meyer, Martin Schrappe, Jan Stary, Ajay Vora, Jan Zuna, Vincent H J van der Velden, Tomasz Szczepanski, Maria Grazia Valsecchi, Rob Pieters
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2021)